Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2025 Earnings Call Transcript February 12, 2026 Vertex Pharmaceuticals ...

The most significant advancement in Gemini 3.1 Pro lies in its performance on rigorous logic benchmarks. Most notably, the model achieved a verified score of 77.1% on ARC-AGI-2.

Google launches Gemini 3.1 Pro with major gains in complex reasoning, multimodal capabilities, and benchmark-leading AI ...

The company has several juicy growth opportunities ahead of it, a market professional tracking its fortunes believes.

Vertex, Inc. is rated a Buy due to steady growth, margin expansion, recurring revenue, and high retention. Learn more about ...

Vertex Pharmaceuticals Incorporated faces slowing Trikafta/Kaftrio sales and a stock-price divergence with peers. Click for this VRTX earnings update.

Learn how the down-market capture ratio evaluates investment manager performance in declining markets with formulas and examples to guide your financial decisions.

How Much of the Bottom Does My Fish Finder See While Ice Fishing?; Why Ciscoes are My Favorite Fish to Pull Through the Ice; and Why the Best Ice Fishing Is Where Other Anglers Won’t Go. | Joe Shead ...

Gemini 3 Deepthink is built for complex reasoning and can take 10–20 minutes per query, helping you get clearer, ...

YouTube CEO Neal Mohan says the platform plans to ‘reduce the spread of low quality AI content.’ YouTube CEO Neal Mohan says the platform plans to ‘reduce the spread of low quality AI content.’ is a ...

Google Gemini Enterprise for Customer Experience challenges where intelligence lives in the CX stack—and who owns the ...

Vertex's core franchise probably won't lead to any surprises, but newer launches could. The company should see significant pipeline progress this year. Vertex looks like a strong buy-and-hold option.